Core Viewpoint - The company, Qingdao Sanboshou Health Technology Co., Ltd., has approved the use of up to RMB 500 million of temporarily idle raised funds for cash management, ensuring that it does not affect the normal operation of fundraising projects and the safety of the raised funds [1][6]. Group 1: Cash Management Details - The company will use the idle raised funds for cash management within a period of 12 months, with individual investment products not exceeding 12 months [1]. - The funds will be used to purchase financial products, including structured deposits, which maintain good liquidity and do not alter the intended use of the raised funds [1][7]. - As of the announcement date, the company has invested a total of RMB 470 million in cash management products that have not yet matured [7]. Group 2: Risk Management - The company has implemented strict risk assessment procedures for the proposed investment financial products, acknowledging potential market volatility [3]. - The chairman will exercise decision-making authority over the investment, including selecting quality financial institutions and defining cash management amounts and products [4]. - Internal audit and supervision mechanisms are in place to monitor cash management activities and ensure compliance with relevant regulations [5]. Group 3: Impact on Operations - The cash management of idle raised funds is aimed at optimizing the efficiency of fund usage without impacting the normal development of the company's main business [6]. - Engaging in cash management is expected to generate investment returns, thereby enhancing the overall performance of the company and providing greater returns for shareholders [6].
青岛三柏硕健康科技股份有限公司关于使用部分暂时闲置募集资金进行现金管理的进展公告